1. Home
  2. NSP vs XNCR Comparison

NSP vs XNCR Comparison

Compare NSP & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

N/A

Current Price

$21.86

Market Cap

834.9M

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$11.70

Market Cap

881.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSP
XNCR
Founded
1986
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
834.9M
881.9M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
NSP
XNCR
Price
$21.86
$11.70
Analyst Decision
Hold
Buy
Analyst Count
3
10
Target Price
$47.67
$22.89
AVG Volume (30 Days)
1.2M
579.8K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
10.78%
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
$6,812,000,000.00
$125,576,000.00
Revenue This Year
$4.27
N/A
Revenue Next Year
$5.43
$6.52
P/E Ratio
N/A
N/A
Revenue Growth
3.51
13.65
52 Week Low
$20.42
$6.92
52 Week High
$93.81
$18.69

Technical Indicators

Market Signals
Indicator
NSP
XNCR
Relative Strength Index (RSI) 26.95 46.38
Support Level N/A $11.02
Resistance Level $48.32 $12.58
Average True Range (ATR) 1.39 0.88
MACD 0.35 0.03
Stochastic Oscillator 20.04 28.44

Price Performance

Historical Comparison
NSP
XNCR

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: